ResMed (RMD)

Key Statistics

EV/EBIT = 27.4x

ROE = 22.7%

Debt/Equity = 18%

FCF Yield = 3.5%

Dividend Yield = .88%

Market Cap = $35.33 billion

The Company

ResMed (RMD) is a medical device company, specializing in solutions for sleep apnea and other respiratory conditions.

Sleep apnea occurs when breathing repeatedly stops during sleep, causing disrupted sleep patterns and reduced oxygen levels in the blood. This can significantly diminish quality of life, leading to issues such as chronic fatigue, difficulty concentrating, and serious health complications, including cardiovascular problems like high blood pressure and an increased risk of heart attack or stroke. ResMed’s products help manage these conditions, improving both sleep quality and overall health outcomes.

Their key products include CPAP machines like the AirSense 11 and AirCurve 11, which deliver pressurized air to keep airways open during sleep.

They offer a variety of CPAP masks, including full-face, nasal, and nasal pillow masks, to ensure a comfortable and effective fit. To improve therapy, ResMed provides accessories like humidifiers and heated tubes for added comfort.